EDGAR Filing Documents for 0001193125-14-114613

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-14-114613

Filing Date

2014-03-25

Accepted

2014-03-25 17:16:52

Documents

Period of Report

2013-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d675342d10k.htm	10-K	991861
2	EX-10.8	d675342dex108.htm	EX-10.8	10280
3	EX-10.14	d675342dex1014.htm	EX-10.14	34966
4	EX-10.19	d675342dex1019.htm	EX-10.19	38996
5	EX-23.1	d675342dex231.htm	EX-23.1	1478
6	EX-31.1	d675342dex311.htm	EX-31.1	6087
7	EX-31.2	d675342dex312.htm	EX-31.2	6120
8	EX-32.1	d675342dex321.htm	EX-32.1	4513
15	GRAPHIC	g675342g08r20.jpg	GRAPHIC	97454
16	GRAPHIC	g675342g81n28.jpg	GRAPHIC	3898
	Complete submission text file	0001193125-14-114613.txt		4029860

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	itci-20131231.xml	EX-101.INS	359471
10	XBRL TAXONOMY EXTENSION SCHEMA	itci-20131231.xsd	EX-101.SCH	33987
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	itci-20131231_cal.xml	EX-101.CAL	51426
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	itci-20131231_def.xml	EX-101.DEF	91320
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	itci-20131231_lab.xml	EX-101.LAB	312115
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	itci-20131231_pre.xml	EX-101.PRE	206073

Mailing Address 3960 BROADWAY NEW YORK NY 10032

Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344

Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)